Marimed (MRMD) Cost of Revenue (2011 - 2026)
Marimed (MRMD) posted quarterly Cost of Revenue of $24.2 million for Q1 2026, up 6.08% year-over-year from $22.8 million in Q1 2025, and down 22.29% quarter-over-quarter from $31.1 million in Q4 2025.
Marimed (MRMD) Cost of Revenue (2011 - 2026) Analysis & Trends
Marimed (MRMD) has reported Cost of Revenue for 16 consecutive years, with $24.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cost of Revenue rose 6.08% year-over-year to $24.2 million; the TTM figure through Mar 2026 stood at $103.3 million (up 7.13% YoY), while the FY2025 annual figure was $101.9 million, up 7.2% from the prior year.
- Cost of Revenue retreated to $24.2 million in Q1 2026 per MRMD's latest filing, from $31.1 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $31.1 million in Q4 2025 and bottomed at $14.3 million in Q1 2022.
- Historically, Cost of Revenue has averaged $22.0 million across 5 years, with a median of $22.0 million in 2023.
- Annual changes were most pronounced in 2022 — Cost of Revenue surged 36.6% — and 2025, when it advanced 0.21%.
- Marimed's Cost of Revenue stood at $20.0 million in 2022, then increased by 7.81% to $21.6 million in 2023, then grew by 21.83% to $26.3 million in 2024, then advanced by 18.46% to $31.1 million in 2025, then declined by 22.29% to $24.2 million in 2026.
- Business Quant data shows MRMD's Cost of Revenue at $24.2 million in Q1 2026, $31.1 million in Q4 2025, and $24.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Marimed | 28.08 Mn | 17.74 Mn | 16.23 Mn | 25.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.70 Mn |
| Jun 30, 2026 | 25.70 Mn |
| Mar 31, 2026 | 24.21 Mn |
| Mar 31, 2026 | 24.21 Mn |
| Dec 31, 2025 | 31.15 Mn |
| Dec 31, 2025 | 31.15 Mn |
| Sep 30, 2025 | 24.40 Mn |
| Sep 30, 2025 | 24.40 Mn |
| Jun 30, 2025 | 23.58 Mn |
| Jun 30, 2025 | 23.58 Mn |
| Mar 31, 2025 | 22.82 Mn |
| Mar 31, 2025 | 22.82 Mn |
| Dec 31, 2024 | 26.29 Mn |
| Dec 31, 2024 | 26.29 Mn |
| Sep 30, 2024 | 23.81 Mn |
| Sep 30, 2024 | 23.81 Mn |
| Jun 30, 2024 | 23.53 Mn |
| Jun 30, 2024 | 23.53 Mn |
| Mar 31, 2024 | 21.46 Mn |
| Mar 31, 2024 | 21.46 Mn |